
CAS 109678-71-9
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
Terazosin EP Impurity F
CAS :Formule :C19H27N5O4Couleur et forme :White To Off-White SolidMasse moléculaire :389.461-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone Hydrochloride
CAS :Produit contrôlé<p>Impurity Terazosin EP Impurity F<br>Applications 1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone Hydrochloride is an impurity (1) of Terazosin (T105000), an α-1-adrenergic blocker (2) that is related to Prazosin (P702325).<br>References 1. Patterson, E. et al.: J. Chromatogr. 1984 Nov 9;311(1):206-12.2. Fort F. et al.: Drug Chem. Toxicol. 1984;7(5):435-49.<br></p>Formule :C19H28ClN5O4Couleur et forme :NeatMasse moléculaire :425.911-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone-d8
CAS :Produit contrôlé<p>Applications Isotope labelled 1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone is an impurity of Terazosin (T105000), an α-1-adrenergic blocker that is related to Prazosin (P702325).<br>References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),<br></p>Formule :C19D8H19N5O4Couleur et forme :NeatMasse moléculaire :397.4981-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone
CAS :<p>1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone is a drug product that is used as an HPLC standard. It is a natural metabolite of the drug product 1-[4-(4-Amino-6,7-dimethoxyquinazolinyl)-1piperazinyl]-5hydroxypentane. The synthesis of this compound has been reported in the literature.<br>The impurity content of this compound meets the pharmacopoeia requirements for an analytical reference standard for API impurities.</p>Formule :C19H27N5O4Degré de pureté :Min. 95%Masse moléculaire :389.45 g/mol



